Algernon Announces Regulatory Submission for Ifenprodil COVID-19 Human Trial in South Korea Pharmaceutical Investing
Revive Therapeutics Engages Novotech as Asia-Pacific CRO for Bucillamine in the Treatment of Infectious Diseases Pharmaceutical Investing
Algernon Announces Positive Feedback from Health Canada for Ifenprodil COVID-19 Phase 2 Human Trial Pharmaceutical Investing
Algernon Provides Update on Phase 2 Human Testing of Ifenprodil for COVID-19 Pharmaceutical Investing
Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test Biotech Investing
BriaCell to Present Clinical Data at 2020 American Society of Clinical Oncology (ASCO) Annual Meeting May 29 Biotech Investing
Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests Biotech Investing
Algernon Submits for Ethics Approval for Phase 2 IPF and Chronic Cough Study Pharmaceutical Investing
